| 1 |
methicillin-resistant Staphylococcus aureus
(18154 times)
|
Communicable Diseases
(3793 times)
|
MSSA (1658 times)
MIC (773 times)
VRE (751 times)
|
1976 Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital.
|
| 2 |
DMPPC-resistant S. aureus
(16 times)
|
Anti-Bacterial Agents
(3 times)
|
MICs (2 times)
S. aureus (2 times)
ACH (1 time)
|
1990 [Antibacterial activities and electron microscopic studies of imipenem in combination with fosfomycin against methicillin and fosfomycin resistant strains of Staphylococcus aureus].
|
| 3 |
methicillin-resistant phenotype
(4 times)
|
Microbiology
(1 time)
|
CFU (1 time)
CMC (1 time)
HLMR (1 time)
|
2011 [Egg crater mattresses: a deposit of methicillin-resistant staphylococcus aureus?].
|
| 4 |
mortality in sufferers.Meticillin-resistant Staphylococcus aureus
(3 times)
|
Health Services Research
(3 times)
|
CI (1 time)
OR (1 time)
|
2013 Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
|
| 5 |
MR S. aureus
(3 times)
|
Optometry
(1 time)
|
MR (3 times)
MSSA (2 times)
CFU (1 time)
|
2014 Carriage of Staphylococcus species in the veterinary visiting dog population in mainland UK: molecular characterisation of resistance and virulence.
|
| 6 |
methicillin-resistant but quinolone-susceptible Staphylococcus aureus
(2 times)
|
Anti-Bacterial Agents
(1 time)
|
CAPTURE (1 time)
|
2002 Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.
|
| 7 |
methicillin/oxacillin resistant
(2 times)
|
Anti-Bacterial Agents
(1 time)
|
CFU (1 time)
ECg (1 time)
hpf (1 time)
|
2002 Detection and expression of methicillin/oxacillin resistance in multidrug-resistant and non-multidrug-resistant Staphylococcus aureus in Central Sydney, Australia.
|
| 8 |
ml for S. aureus
(2 times)
|
Veterinary Medicine
(1 time)
|
BWG (1 time)
CLSI (1 time)
FCR (1 time)
|
2018 Biological activity of Cymbopogon schoenanthus essential oil.
|
| 9 |
MRSA group
(2 times)
|
Hip Joint
(1 time)
|
CRP (1 time)
MSSA (1 time)
|
2014 Clinical Characteristics of Methicillin-resistant Staphylococcus aureus Infection for Chronic Periprosthetic Hip and Knee Infection.
|
| 10 |
multidrug-resistant
(2 times)
|
|
GC-MS (1 time)
MIC (1 time)
PK (1 time)
|
2014 Chemical Composition, Modulatory Bacterial Resistance and Antimicrobial Activity of Essential Oil the Hyptis martiusii Benth by Direct and Gaseous Contact.
|
| 11 |
multiresistant strains
(2 times)
|
Biochemistry
(1 time)
|
Rot (1 time)
|
2009 An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis?
|
| 12 |
IntroductionMeticillin-resistant Staphylococcus aureus
(1 time)
|
Communicable Diseases
(1 time)
|
---
|
2019 Changing epidemiology of meticillin-resistant Staphylococcus aureus in 42 hospitals in the Dutch-German border region, 2012 to 2016: results of the search-and-follow-policy.
|
| 13 |
macrolides
(1 time)
|
Biology
(1 time)
|
MICs (1 time)
|
2018 Dolastane diterpenes from Canistrocarpus cervicornis and their effects in modulation of drug resistance in Staphylococcus aureus.
|
| 14 |
majority of oxacillin-resistant
(1 time)
|
Communicable Diseases
(1 time)
|
VRE (1 time)
|
2010 Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008).
|
| 15 |
MDRB isolates
(1 time)
|
Geriatrics
(1 time)
|
ESBL-E (1 time)
MDRB (1 time)
VRE (1 time)
|
2012 Health outcomes of older patients colonized by multi-drug resistant bacteria (MDRB): a one-year follow-up study.
|
| 16 |
mecA to S. aureus
(1 time)
|
Veterinary Medicine
(1 time)
|
MALDI-TOF MS (1 time)
MRCNS (1 time)
|
2011 Prevalence and characteristics of methicillin-resistant coagulase-negative staphylococci from livestock, chicken carcasses, bulk tank milk, minced meat, and contact persons.
|
| 17 |
mechanistic range shift analysis
(1 time)
|
Environmental Health
(1 time)
|
---
|
2017 A framework for modelling range shifts and migrations: asking when, whither, whether and will it return.
|
| 18 |
membranes of both Gram-positive
(1 time)
|
Chemistry
(1 time)
|
HSA (1 time)
|
2016 Design, synthesis and biological evaluation of berberine-benzimidazole hybrids as new type of potentially DNA-targeting antimicrobial agents.
|
| 19 |
Methicillin and gentamicin resistant strains of Staphylococcus aureus
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
---
|
1988 In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.
|
| 20 |
methicillin susceptible and resistant staphylococcus aureus respectively
(1 time)
|
Biochemistry
(1 time)
|
E. coli (1 time)
FCA (1 time)
MIC (1 time)
|
2018 Fatty acid conjugated pyridinium cationic amphiphiles as antibacterial agents and self-assembling nano carriers.
|
| 21 |
methicillin, causes the rise of antibiotic-resistant strains
(1 time)
|
Veterinary Medicine
(1 time)
|
AFLP (1 time)
MSSA (1 time)
|
2004 Staphylococcus aureus: study of genomic similarity of strains isolated in veterinary pathology using amplified fragment length polymorphism (AFLP).
|
| 22 |
methicillin- and cephem-resistant subclones of Staphylococcus aureus
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
PBPs (1 time)
|
1985 Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus.
|
| 23 |
methicillin- resistant <i>S. aureus</i>
(1 time)
|
Medicine
(1 time)
|
WWTPs (1 time)
|
2020 Occupational exposure to Staphylococcus aureus in the wastewater treatment plants environment.
|
| 24 |
methicillin-resistant phenotype in S. aureus
(1 time)
|
Antineoplastic Agents
(1 time)
|
DD (1 time)
MIC (1 time)
OS-MRSA (1 time)
|
2014 mecA-positive methicillin-sensitive Staphylococcus aureus clinical isolates in Zenica-Doboj Canton, Bosnia and Herzegovina.
|
| 25 |
methicillin-resistant Staphylococcus aureus prevalence and outbreaks
(1 time)
|
Health Services
(1 time)
|
AMR (1 time)
|
2007 Development and validation of measures to assess prevention and control of AMR in hospitals.
|
| 26 |
Methicillin-susceptible and -resistant
(1 time)
|
Medicine
(1 time)
|
cSSSI (1 time)
HDSD (1 time)
|
2008 A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.
|
| 27 |
methide and 8,11,13-totaratriene-12,13-diol showed potent activities against S. aureus
(1 time)
|
Chemistry
(1 time)
|
---
|
2010 Syntheses and antibacterial activities of diterpene catechol derivatives with abietane, totarane and podocarpane skeletons against methicillin-resistant Staphylococcus aureus and Propionibacterium acnes.
|
| 28 |
methods for detection of S. aureus resistant to oxacillin
(1 time)
|
Molecular Biology
(1 time)
|
SA/MRSA (1 time)
|
2019 Rapid Methods for Detection of MRSA in Clinical Specimens.
|
| 29 |
methycyllin-resistant Staphylococcus aureus and Staphylococcus epidermidis
(1 time)
|
Epidemiology
(1 time)
|
SBP (1 time)
|
2006 [Sepsis and other serious infection patients treated in department of infectious diseases--in own experiences].
|
| 30 |
methycyllin-susceptible and resistant strains
(1 time)
|
Dermatology
(1 time)
|
S. aureus (1 time)
S. pyogenes (1 time)
|
2021 Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
|
| 31 |
methylrestant cultures
(1 time)
|
General Surgery
(1 time)
|
AMP (1 time)
|
2010 [Resistance to antibiotics of nosocomial cultures of Staphylococcus aureus in surgical departments of Ukraine in 2009 year].
|
| 32 |
METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS
(1 time)
|
General Surgery
(1 time)
|
---
|
2002 [Risk factors and treatment of methicillin-resistant Staphylococcus aureus infections].
|
| 33 |
MIC values for clinical Staphylococci strains
(1 time)
|
Chemistry
(1 time)
|
---
|
2013 Synthesis and in vitro antibacterial activity of 5-halogenomethylsulfonyl- benzimidazole and benzotriazole derivatives.
|
| 34 |
microbes especially Staph. aureus, P. aeruginosa, and Staph. aureus
(1 time)
|
Complementary Therapies
(1 time)
|
AERc (2 times)
HPX (1 time)
MPO (1 time)
|
2019 Evaluation of the Biological Effects of Lyophilized Hydrophilic Extract of Rhus coriaria on Myeloperoxidase (MPO) Activity, Wound Healing, and Microbial Infections of Skin Wound Tissues.
|
| 35 |
microgram for Streptococcus pneumoniae and Staphylococcus aureus
(1 time)
|
Communicable Diseases
(1 time)
|
MICs (1 time)
|
1997 Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing.
|
| 36 |
microorganism
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
---
|
2016 Patient and public understanding and knowledge of antimicrobial resistance and stewardship in a UK hospital: should public campaigns change focus?
|
| 37 |
microorganisms including: Staphylococcus aureus
(1 time)
|
|
FT-IR (1 time)
MICs (1 time)
MLCs (1 time)
|
2020 Eco-friendly synthesis of silver nanoparticles by Bacillus subtilis and their antibacterial activity.
|
| 38 |
mixed culture with Staphylococcus aureus
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
ABK (1 time)
GM (1 time)
NTL (1 time)
|
1994 [Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
|
| 39 |
mL against S. aureus
(1 time)
|
Biochemistry
(1 time)
|
MIC (1 time)
|
2019 In vitro anti-bacterial and time kill evaluation of binuclear tricyclohexylphosphanesilver(I) dithiocarbamates, {Cy3PAg(S2CNRR')}2.
|
| 40 |
model Gram-positive
(1 time)
|
Biocompatible Materials
(1 time)
|
---
|
2020 Controllable hydrogen bonded self-association for the formation of multifunctional antimicrobial materials.
|
| 41 |
monocytogenes, Staphylococcus aureus
(1 time)
|
Microbiological Phenomena
(1 time)
|
---
|
2016 Thusin, a Novel Two-Component Lantibiotic with Potent Antimicrobial Activity against Several Gram-Positive Pathogens.
|
| 42 |
more isolates of SA and SC are resistant to methicillin
(1 time)
|
Dermatology
(1 time)
|
cSSSI (1 time)
SA (1 time)
SC (1 time)
|
2006 Dalbavancin: a review for dermatologists.
|
| 43 |
more readmissions to hospitals
(1 time)
|
Nursing
(1 time)
|
CDI (1 time)
ESBL (1 time)
VRE (1 time)
|
2015 Quantifying the Exposure to Antibiotic-Resistant Pathogens Among Patients Discharged From a Single Hospital Across All California Healthcare Facilities.
|
| 44 |
more susceptible to oxacillin, resistance to oxacillin by highly-resistant strains
(1 time)
|
Neoplasms
(1 time)
|
CPZ (1 time)
MSSA (1 time)
TZ (1 time)
|
2006 Thioridazine reduces resistance of methicillin-resistant staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump.
|
| 45 |
most common bacteria weremethicillin-resistant Staphylococcus aureus
(1 time)
|
|
CPR (1 time)
IE (1 time)
MSSA (1 time)
|
2020 Infective Endocarditis: Preliminary Results of a Cohort Study in the Southern Italian Population.
|
| 46 |
Most S aureus strains are resistant to methicillin
(1 time)
|
Communicable Diseases
(1 time)
|
VRSA (1 time)
|
2015 Dissemination of antibiotic resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant S aureus strains isolated from hospital effluents.
|
| 47 |
movements, such as walking, running or swimming
(1 time)
|
Neurology
(1 time)
|
HC-3 (1 time)
|
1980 Effects of hemicholinium-3 and choline on hippocampal electrical activity during immobility vs. movement.
|
| 48 |
MR Staphylococcus aureus
(1 time)
|
Dermatology
(1 time)
|
MR (1 time)
MRSP (1 time)
MRSS (1 time)
|
2010 The prevalence of carriage of meticillin-resistant staphylococci by veterinary dermatology practice staff and their respective pets.
|
| 49 |
MRSA and VRE infection or colonization
(1 time)
|
Communicable Diseases
(1 time)
|
CI (1 time)
HAIs (1 time)
HR (1 time)
|
2009 Exposure to hospital roommates as a risk factor for health care-associated infection.
|
| 50 |
MRSA patients
(1 time)
|
Communicable Diseases
(1 time)
|
---
|
2007 [Genesis of methicillin-resistant Staphylococcus aureus and selective antibacterial injection pressure].
|
| 51 |
MRSA- and P. aeruginosa-induced nosocomial pneumonia was observed
(1 time)
|
Communicable Diseases
(1 time)
|
---
|
2001 [Importance of a cleaning in upper airways by using povidone iodine for the prevention of nosocomial pneumonia].
|
| 52 |
MRSA-hVI
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
MDRSP (1 time)
|
2007 In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
|
| 53 |
multi resistant staphylococcus glococcus
(1 time)
|
Nursing
(1 time)
|
---
|
1987 Occupational health dilemma.
|
| 54 |
multi-resistant staphylococcus
(1 time)
|
General Surgery
(1 time)
|
US (1 time)
|
2008 Liver abscess in neonates.
|
| 55 |
Multi-species biofilm of Staphylococcus aureus oxacillin resistant
(1 time)
|
Biomimetics
(1 time)
|
DFR (1 time)
SSD (1 time)
|
2015 Anti-biofilm activity of chitosan gels formulated with silver nanoparticles and their cytotoxic effect on human fibroblasts.
|
| 56 |
multidrug-resistant organisms
(1 time)
|
Rehabilitation
(1 time)
|
ESBL (1 time)
MDRO (1 time)
|
2015 [Multidrug-Resistant Organisms (MDRO) in Rehabilitation Clinics in the Rhine-Main District, Germany, 2014: Risk Analysis and Hygiene Procedures].
|
| 57 |
multiple antibiotics, including those resistant to methicillin
(1 time)
|
Communicable Diseases
(1 time)
|
---
|
1997 Widespread dissemination of epidemic MRSA in German hospitals.
|
| 58 |
multiQACs with superior profiles against resistant
(1 time)
|
|
MSSA (1 time)
QACs (1 time)
|
2015 Bioorganic Investigation of Multicationic Antimicrobials to Combat QAC-Resistant Staphylococcus aureus.
|
| 59 |
muscular vessels-related sympathetic activity
(1 time)
|
Aerospace Medicine
(1 time)
|
BP (1 time)
HR (1 time)
PWAO (1 time)
|
2011 [Effect of strength-building training on manifestation of pressor reflex from working muscles receptors].
|
A Search Service for Abbreviation / Long Form